See the Full Picture.
Published loading...Updated

Takeda Pharmaceutical Company Limited (TAK) Q3 2023 Earnings Call Transcript

Summary by Ground News
Takeda Pharmaceutical Company Limited (NYSE:TAK) Q3 2023 Earnings Conference Call February 2, 2023 5:30 AM ET Company Participants Christopher OReilly - Head, Investor Relations Christophe Weber - President and Chief Executive Officer Andy Plump - President, R&D Costa Saroukos - Chief Financial Officer Ramona Sequeira - President,. Global Portfolio Division Conference Call Participants Hidemaru Yamaguchi - Citigroup Motoya Koutani - Nomura Securities Seiji Wakao - JPMorgan Shinichiro Muraoka - Morgan Stanley

Bias Distribution

  • 100% of the sources lean Right
100% Right
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Seeking Alpha broke the news in United States on Friday, February 3, 2023.
Sources are mostly out of (0)